In November the Food and Drug Administration (FDA) warned the direct-to-consumer gene testing company 23andMe to stop marketing its $99 genotype screening test. The FDA's letter gave 23andMe 15 days to respond, warning that if the agency didn't like what it heard, the potential results could "include, but are not limited to, seizure, injunction, and civil money penalties." Ronald Bailey says that despite the FDA's parade of horrible hypotheticals, the bigger risk is that increased regulation will slow down the progress of beneficial genetic testing and treatment.
The proposed bill from Assembly Members Evan Low and Cristina Garcia would require stores to have one unisex section for children's products and apparel.
A SWAT Team Destroyed This Innocent Woman's House While Chasing a Fugitive. The City Refuses To Pay for Damages.
"I've lost everything," says Vicki Baker.
The Senate is preparing to pass a $1.9 trillion COVID-19 relief bill that has very little to do with the pandemic, and we all know it. Congress should admit as much.
We can justifiably hope for normalcy by Independence Day.